Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 13-Oct-09 10:39 AM View:  | Parsons C. Lowell Director | Urigen Pharmaceuticals, Inc. (URGP) | 05-Oct-09 | Purchase | 10,000 | $0.06 | $650.00 | < 1% 1.96M to 1.97M | |
| 13-Oct-09 10:39 AM View: | Parsons C. Lowell Director | Urigen Pharmaceuticals, Inc. (URGP) | 02-Oct-09 | Purchase | 13,000 | $0.06 | $845.00 | < 1% 1.95M to 1.96M | |
| 13-Oct-09 10:39 AM View: | Parsons C. Lowell Director | Urigen Pharmaceuticals, Inc. (URGP) | 01-Oct-09 | Purchase | 30,000 | $0.06 | $1,900.00 | 2% 1.95M to 1.98M | |
| 05-Aug-09 11:58 AM View: | Parsons C. Lowell Director | Urigen Pharmaceuticals, Inc. (URGP) | 28-Jul-09 | Purchase | 20,000 | $0.07 | $1,400.00 | 1% 1.91M to 1.93M | |
| 15-Jun-09 3:47 PM View: | Shmagin Martin E Chief Financial Officer Director | Urigen Pharmaceuticals, Inc. (URGP) | 11-Jun-09 | Purchase | 1,500 | $0.08 | $120.00 | < 1% 3.14M to 3.14M | |
| 05-Jun-09 5:33 PM View: | Parsons C. Lowell Director | Urigen Pharmaceuticals, Inc. (URGP) | 01-Jun-09 | Purchase | 7,500 | $0.09 | $675.00 | < 1% 1.9M to 1.91M | |
| 29-May-09 12:28 PM View: | Parsons C. Lowell Director | Urigen Pharmaceuticals, Inc. (URGP) | 26-May-09 | Purchase | 7,500 | $0.09 | $637.50 | < 1% 1.89M to 1.9M | |
| 29-May-09 12:28 PM View: | Parsons C. Lowell Director | Urigen Pharmaceuticals, Inc. (URGP) | 22-May-09 | Purchase | 7,500 | $0.08 | $600.00 | < 1% 1.88M to 1.89M | |
| 18-Mar-09 9:57 PM View: | Shmagin Martin E Chief Financial Officer Director | Urigen Pharmaceuticals, Inc. (URGP) | 18-Mar-09 | Market Purchase | 1,000 | $0.09 | $90.00 | < 1% 3.14M to 3.14M | (44%) |
| 26-Mar-09 3:48 PM View: | Parsons C. Lowell Director | Urigen Pharmaceuticals, Inc. (URGP) | 17-Mar-09 | Purchase | 2,500 | $0.90 | $2,250.00 | < 1% 1.88M to 1.88M | (94%) |
| 18-Mar-09 9:57 PM View: | Shmagin Martin E Chief Financial Officer Director | Urigen Pharmaceuticals, Inc. (URGP) | 16-Mar-09 | Market Purchase | 2,000 | $0.09 | $170.00 | < 1% 3.13M to 3.14M | (41%) |
| 17-Mar-09 2:23 PM View: | Parsons C. Lowell Director | Urigen Pharmaceuticals, Inc. (URGP) | 16-Mar-09 | Purchase | 3,000 | $0.80 | $2,400.00 | < 1% 1.88M to 1.88M | (94%) |
| 16-Mar-09 10:06 AM View: | Garner William J Chief Executive Officer Director 10% Owner | Urigen Pharmaceuticals, Inc. (URGP) | 13-Mar-09 | Market Purchase | 1,000 | $0.09 | $90.00 | < 1% 18.59M to 18.59M | (44%) |
| 13-Mar-09 6:28 PM View: | Shmagin Martin E Chief Financial Officer Director | Urigen Pharmaceuticals, Inc. (URGP) | 13-Mar-09 | Market Purchase | 1,000 | $0.09 | $90.00 | < 1% 3.13M to 3.13M | (44%) |
| 18-Mar-09 4:27 PM View: | Garner William J Chief Executive Officer Director 10% Owner | Urigen Pharmaceuticals, Inc. (URGP) | 13-Mar-09 | Market Purchase | 1,000 | $0.09 | $90.00 | < 1% 18.59M to 18.59M | (44%) |
| 17-Mar-09 2:23 PM View: | Parsons C. Lowell Director | Urigen Pharmaceuticals, Inc. (URGP) | 13-Mar-09 | Purchase | 7,500 | $0.90 | $6,750.00 | < 1% 1.87M to 1.88M | (94%) |
| 13-Mar-09 3:29 PM View: | Garner William J Chief Executive Officer Director 10% Owner | Urigen Pharmaceuticals, Inc. (URGP) | 11-Mar-09 | Market Purchase | 1,000 | $0.09 | $90.00 | < 1% 18.58M to 18.59M | (44%) |
| 13-Mar-09 6:28 PM View: | Shmagin Martin E Chief Financial Officer Director | Urigen Pharmaceuticals, Inc. (URGP) | 11-Mar-09 | Market Purchase | 2,000 | $0.09 | $180.00 | < 1% 3.13M to 3.13M | (44%) |
| 13-Mar-09 6:28 PM View: | Shmagin Martin E Chief Financial Officer Director | Urigen Pharmaceuticals, Inc. (URGP) | 09-Mar-09 | Market Purchase | 1,000 | $0.09 | $90.00 | < 1% 3.13M to 3.13M | (44%) |
| 09-Mar-09 9:47 AM View: | Parsons C. Lowell Director | Urigen Pharmaceuticals, Inc. (URGP) | 06-Mar-09 | Market Purchase | 6,000 | $0.08 | $480.00 | < 1% 1.86M to 1.87M | (38%) |
| 10-Mar-09 1:24 PM View: | Shmagin Martin E Chief Financial Officer Director | Urigen Pharmaceuticals, Inc. (URGP) | 06-Mar-09 | Market Purchase | 1,000 | $0.08 | $80.00 | < 1% 3.13M to 3.13M | (38%) |
| 10-Mar-09 1:24 PM View: | Shmagin Martin E Chief Financial Officer Director | Urigen Pharmaceuticals, Inc. (URGP) | 05-Mar-09 | Market Purchase | 4,000 | $0.08 | $320.00 | < 1% 3.13M to 3.13M | (38%) |
| 06-Mar-09 6:21 PM View: | Garner William J Chief Executive Officer Director 10% Owner | Urigen Pharmaceuticals, Inc. (URGP) | 05-Mar-09 | Market Purchase | 5,000 | $0.08 | $400.00 | < 1% 18.58M to 18.58M | (38%) |
| 09-Mar-09 9:47 AM View: | Parsons C. Lowell Director | Urigen Pharmaceuticals, Inc. (URGP) | 03-Mar-09 | Market Purchase | 1,500 | $0.10 | $150.00 | < 1% 1.86M to 1.86M | (50%) |
| 02-Mar-09 11:52 AM View: | Parsons C. Lowell Director | Urigen Pharmaceuticals, Inc. (URGP) | 27-Feb-09 | Market Purchase | 5,000 | $0.10 | $500.00 | < 1% 1.86M to 1.86M | (50%) |
| 02-Mar-09 11:52 AM View: | Parsons C. Lowell Director | Urigen Pharmaceuticals, Inc. (URGP) | 26-Feb-09 | Market Purchase | 10,000 | $0.10 | $1,000.00 | < 1% 1.85M to 1.86M | (50%) |
| 26-Feb-09 5:24 PM View: | Shmagin Martin E Chief Financial Officer Director | Urigen Pharmaceuticals, Inc. (URGP) | 25-Feb-09 | Market Purchase | 2,500 | $0.11 | $270.00 | < 1% 3.12M to 3.13M | (54%) |
| 02-Mar-09 11:52 AM View: | Parsons C. Lowell Director | Urigen Pharmaceuticals, Inc. (URGP) | 25-Feb-09 | Market Purchase | 5,000 | $0.10 | $500.00 | < 1% 1.84M to 1.85M | (50%) |
| 26-Feb-09 5:23 PM View: | Garner William J Chief Executive Officer Director 10% Owner | Urigen Pharmaceuticals, Inc. (URGP) | 25-Feb-09 | Market Purchase | 1,000 | $0.10 | $100.00 | < 1% 18.58M to 18.58M | (50%) |
| 26-Feb-09 5:24 PM View: | Shmagin Martin E Chief Financial Officer Director | Urigen Pharmaceuticals, Inc. (URGP) | 24-Feb-09 | Market Purchase | 1,000 | $0.12 | $120.00 | < 1% 3.12M to 3.12M | (58%) |
| 03-Feb-09 12:59 PM View: | Garner William J Chief Executive Officer Director 10% Owner | Urigen Pharmaceuticals, Inc. (URGP) | 30-Jan-09 | Market Purchase | 17,800 | $0.13 | $2,392.00 | < 1% 18.56M to 18.58M | (63%) |
| 03-Feb-09 3:12 PM View: | Shmagin Martin E Chief Financial Officer Director | Urigen Pharmaceuticals, Inc. (URGP) | 29-Jan-09 | Market Purchase | 4,000 | $0.11 | $430.00 | < 1% 3.12M to 3.12M | (53%) |
| 03-Feb-09 12:59 PM View: | Garner William J Chief Executive Officer Director 10% Owner | Urigen Pharmaceuticals, Inc. (URGP) | 29-Jan-09 | Market Purchase | 16,000 | $0.15 | $2,400.00 | < 1% 18.54M to 18.56M | (67%) |
| 30-Jan-09 4:42 PM View: | Shmagin Martin E Chief Financial Officer Director | Urigen Pharmaceuticals, Inc. (URGP) | 28-Jan-09 | Market Purchase | 10,500 | $0.13 | $1,315.00 | < 1% 3.11M to 3.12M | (60%) |
| 29-Jan-09 6:40 PM View: | Garner William J Chief Executive Officer Director 10% Owner | Urigen Pharmaceuticals, Inc. (URGP) | 27-Jan-09 | Purchase | 10,000 | $0.12 | $1,200.00 | < 1% 18.53M to 18.54M | (58%) |
| 30-Jan-09 4:42 PM View: | Shmagin Martin E Chief Financial Officer Director | Urigen Pharmaceuticals, Inc. (URGP) | 27-Jan-09 | Market Purchase | 15,000 | $0.10 | $1,450.00 | < 1% 3.09M to 3.11M | (48%) |
| 29-Jan-09 6:40 PM View: | Garner William J Chief Executive Officer Director 10% Owner | Urigen Pharmaceuticals, Inc. (URGP) | 26-Jan-09 | Market Purchase | 5,000 | $0.17 | $850.00 | < 1% 18.53M to 18.53M | (71%) |
| 26-Jan-09 5:43 PM View: | Shmagin Martin E Chief Financial Officer Director | Urigen Pharmaceuticals, Inc. (URGP) | 23-Jan-09 | Market Purchase | 20,000 | $0.16 | $3,200.00 | (< 1%) 3.11M to 3.09M | 69% |
| 26-Jan-09 5:43 PM View: | Shmagin Martin E Chief Financial Officer Director | Urigen Pharmaceuticals, Inc. (URGP) | 22-Jan-09 | Market Purchase | 20,000 | $0.14 | $2,700.00 | (< 1%) 3.09M to 3.07M | 63% |
| 22-Jan-09 6:06 PM View: | Garner William J Chief Executive Officer Director 10% Owner | Urigen Pharmaceuticals, Inc. (URGP) | 21-Jan-09 | Purchase | 48,000 | $0.05 | $2,160.00 | < 1% 18.48M to 18.53M | 11% |
| 21-Jan-09 10:35 AM View: | Garner William J Chief Executive Officer Director 10% Owner | Urigen Pharmaceuticals, Inc. (URGP) | 20-Jan-09 | Market Purchase | 5,000 | $0.05 | $225.00 | < 1% 18.48M to 18.48M | 11% |
| 21-Jan-09 10:35 AM View: | Shmagin Martin E Chief Financial Officer Director | Urigen Pharmaceuticals, Inc. (URGP) | 20-Jan-09 | Purchase | 100,000 | $0.26 | $26,000.00 | 2% 5.93M to 6.03M | (81%) |
| 21-Jan-09 10:35 AM View: | Shmagin Martin E Chief Financial Officer Director | Urigen Pharmaceuticals, Inc. (URGP) | 20-Jan-09 | Market Purchase | 40,000 | $0.10 | $3,950.00 | < 1% 6.03M to 6.07M | (49%) |
| 02-Jul-07 4:57 PM View: | McGraw Benjamin F III COB, President and CEO Director | Urigen Pharmaceuticals, Inc. (URGP) | 30-Jun-07 | Payment of Exercise | 1,771 | $0.16 | $283.36 | (3%) 54.9K to 53.12K | 7% |
| 30-Apr-07 7:33 PM View: | McGraw Benjamin F III COB, President and CEO Director | Urigen Pharmaceuticals, Inc. (URGP) | 30-Apr-07 | Payment of Exercise | 2,657 | $0.26 | $690.82 | (5%) 57.55K to 54.9K | 43% |
| 31-Jan-07 7:01 PM View: | McGraw Benjamin F III COB, President and CEO Director | Urigen Pharmaceuticals, Inc. (URGP) | 31-Jan-07 | Payment of Exercise | 3,162 | $0.26 | $822.12 | (5%) 60.71K to 57.55K | 43% |
| 01-Nov-06 7:19 PM View: | Reddington John J Chief Operating Officer | Urigen Pharmaceuticals, Inc. (URGP) | 31-Oct-06 | Payment of Exercise | 4,834 | $0.61 | $2,948.74 | (14%) 34.3K to 29.46K | 76% |
| 01-Nov-06 7:15 PM View: | McGraw Benjamin F III COB, President and CEO Director | Urigen Pharmaceuticals, Inc. (URGP) | 31-Oct-06 | Payment of Exercise | 2,657 | $0.61 | $1,620.77 | (4%) 63.37K to 60.71K | 76% |
| 01-Nov-06 7:22 PM View: | Markey Joseph A VP of Finance & Admin. | Urigen Pharmaceuticals, Inc. (URGP) | 31-Oct-06 | Payment of Exercise | 2,922 | $0.61 | $1,782.42 | (12%) 25.38K to 22.46K | 76% |
| 31-Jul-06 8:19 PM View: | Reddington John J Chief Operating Officer | Urigen Pharmaceuticals, Inc. (URGP) | 31-Jul-06 | Payment of Exercise | 1,318 | $0.40 | $527.20 | (4%) 35.61K to 34.3K | 63% |
